US equities |
SPCX $171.09 ▲+0.00% NVDA $238.90 ▲+0.00% MU $1,063.96 ▲+0.00% SDEV $3.94 ▲+0.00% SNDK $1,704.16 ▲+0.00% AMD $631.75 ▲+0.00% SKHY $195.02 ▲+0.00% TSLA $378.73 ▲+0.00%
FinancialContent

Latest News about NASDAQ:COYA

Recent news which mentions NASDAQ:COYA

COYA Stock Earnings: Coya Therapeutics Misses EPS, Misses Revenue for Q2 2024
Tickers COYA
Tags COYA Earnings Reports Market News
From InvestorPlace
COYA Stock Earnings: Coya Therapeutics Misses EPS for Q1 2024
Tickers COYA
Tags NASDAQ:COYA COYA Earnings Reports
From InvestorPlace
COYA Stock Earnings: Coya Therapeutics Reported Results for Q4 2023
Tickers COYA
Tags Market News COYA Today's Market
From InvestorPlace
Headline
Tags NASDAQ:COYA
From News Direct
There Is No Cure For ALS, But Coya Therapeutics Might Have The Answer According To A New Clinical Study
Tickers COYA
Tags NASDAQ:COYA
From News Direct
Coya Therapeutics Enters First-Of-Its-Kind Partnership With Multi-Billion Dollar Drug Company — Why This Is a Major Moment For Drug Development
Tickers BLUE COYA GOVX LLY
Tags NASDAQ:COYA
From News Direct
Coya Therapeutics’ COYA 302 Treating ALS Proves Effective In Proof-Of-Concept Academic Clinical Study
Tickers COYA
Tags NASDAQ:COYA
From News Direct
Houston-Based Coya Therapeutics Partners With Multi-Billion Dollar Global Drug Company Dr. Reddy’s Laboratories To License and Commercialize COYA 302
Tickers COYA RDY
Tags NASDAQ:COYA
From News Direct
This Company Is Focused on Treg-Enhancing Therapies - Could This Be Medicine’s Next Frontier?
Tickers COYA LLY NVS
Tags NASDAQ:COYA
From News Direct
Houston-Based Coya Therapeutics To Present Results From ALS Clinical Study Data For Its Investigational Biologic Combination at the 2023 MDA Clinical & Scientific Conference in Dallas
Tickers COYA
Tags NASDAQ:COYA
From News Direct
Coya Therapeutics’ Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments
Tickers COYA XGN
Tags NASDAQ:COYA
From News Direct